Lancashire and South Cumbria
Formulary
Formulary
Sub Chapters : 06 Endocrine system
- Anterior pituitary hormones
- Anti-androgens
- Antidiuretic hormone antagonists
- Anti-oestrogens
- Antithyroid drugs
- Biguanides
- Biphasic insulins
- Bisphosphonates
- Bisphosphonates and other drugs affecting bone metabolism
- Bromocriptine and other dopaminergic drugs
- Calcitonin and parathyroid hormone
- Chronic hypoglycaemia
- Denosumab
- Diabetic nephropathy
- Diagnostic and monitoring agents for diabetes mellitus
- DPP4 inhibitors (gliptins)
- Drugs affecting gonadotrophins
- Ethinylestradiol
- GLP1 agonists
- Glucocorticoid therapy
- Gonadorelin analogues
- Growth hormone receptor antagonists
- Hypodermic equipment
- Hypothalamic and anterior pituitary hormones and anti-oestrogens
- Hypothalmic hormones and protirelin
- Intermediate Acting Insulin
- Intestinal alpha glucosidase inhibitor
- Long Acting Insulin Analogues
- Male sex hormones and antagonists
- Oestrogens
- Oestrogens and HRT
- Other antidiabetic drugs
- Other endocrine drugs
- Posterior pituitary hormones
- Progestogens
- Raloxifene
- Rapid Acting Insulin Analogues
- Replacement therapy
- SGLT2 inhibitors
- Short-acting insulins
- Strontium renelate
- Sulfonylurea
- Thiazolidinediones
- Thyroid hormones
- Treatment of hypoglycaemia